Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Samsung Biologics
Samsung Biologics
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Cleanroom expert ABN Cleanroom Technology announces launch of ABN Labs
The Belgium-based European cleanroom solutions firm has established a new subsidiary to expand into the laboratory sector
Cleanroom laundry opens in Germany to serve Austria and Eastern Europe
The full-service cleanroom laundry expert has opened a new facility near the Austrian border to ensure reliable supplies for customers in southern Germany, Austria, and Eastern...
Should you automate your processes in pharmaceutical sterilisation?
A look at the factors that come into play when deciding whether to integrate automation into pharmaceutical manufacturing processes. Jordi Martinez from Telstar explains
Sovereign Commercial Installations builds ISO Class 7 medical device cleanroom
The UK-based construction expert has completed the design and build of a new cleanroom for a long-standing medical device manufacturing client
Cleanroom expert CRB renovates Bay Area office to support future growth in global life sciences hub
The US-based cleanroom design and build has renovated its 15,000 sqft office in the Bay Area
Upcoming event
Interphex
16-18 April 2024 | Conference and Exhibition | New York, US
See all
Related Content
Pharmaceutical
Samsung Biologics selects company to automate microbiology QC testing
Samsung Biologics has selected Rapid Micro Biosystems’ Growth Direct platform to automate critical microbiology quality control testing
Sustainability
CDMO Samsung Biologics receives Terra Carta Seal for sustainable operations
The South Korean pharmaceutical CDMO has built an environmental management strategy that includes process optimisation, renewable energy transition, and minimising the use of single-use products
Pharmaceutical
Samsung Biologics appoints industry veteran as CEO
Samsung Biologics has announced John Rim as its President and CEO
Finance
Samsung Biologics plans $2bn 'Super Plant' for biomanufacturing
The company has also said that it is in negotiations with the authorities at Incheon Free Economic Zone to purchase additional land for its second bio complex
Pharmaceutical
Samsung BioLogics Plant 3 starts cGMP production
Facility in Incheon, South Korea, features 180,000L capacity, 20% more than its sister plant. The site passed validation in 10 months
Subscribe now